A Pilot Study of Metformin to Reduce Cerebrovascular Dysfunction in Participants With HIV and Metabolic Syndrome.

Clinical trial NCT05571319 · COMPLETED

Trial details

NCT number: NCT05571319
Sponsor: University of Stellenbosch
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metabolic Syndrome HIV Seropositivity

Start date: 2022-08-11
Primary completion: 2025-03-24
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.